Predictors of Non-Fulfillment of Reperfusion Therapy in Patients With ST-Elevation Acute Coronary Syndrome

被引：0

作者：

Altarev, S. S. ^{[1
]}

Barbarash, O. L. ^{[1
]}

Pomeshkina, S. A. ^{[1
]}

Kashtalap, V. V. ^{[1
]}

Zykov, M. V. ^{[1
]}

Tavlueva, E. V. ^{[1
]}

Barbarash, L. S. ^{[1
]}

机构：

[1] Russian Acad Med Sci, Siberian Branch, Res Inst Complex Issues Cardiovasc Dis, Kemerovo 650002, Russia

来源：

KARDIOLOGIYA | 2012年 / 52卷 / 06期

关键词：

acute coronary syndrome; reperfusion therapy; ACUTE MYOCARDIAL-INFARCTION; ASSOCIATION TASK-FORCE; ELDERLY-PATIENTS; NATIONAL REGISTRY; THROMBOLYTIC THERAPY; PERFORMANCE-MEASURES; AMERICAN-COLLEGE; GLOBAL REGISTRY; UNITED-STATES; EVENTS GRACE;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

At present reperfusion therapy in ST-elevation (STE) acute coronary syndrome (ACS) is carried out in majority of countries not more than in 70% of cases. We analyzed predictors of non-fulfillment of reperfusion therapy in patients with STEACS included into ACS registry conducted in the Kemerovo cardiological dispensary. Reperfusion therapy was not carried out in 154 patients with STEACS (36.2%). Main predictors of non-fulfillment of reperfusion were age older than 75 years (odds ratio [OR] 47.97, 95% confidence interval [CI] 19.47-118.21), admission later than in 12 hours after onset of disease (OR 4.29, 95%CI 1.52-12.13), history of myocardial infarction (OR 2.68, 95%CI 1.11-6.48). Thus there are factors including subjective ones which preclude full-fledged use of contemporary recommendations on the management of patients with STEACS

引用

页码：4 / 9

页数：6

共 50 条

[31] Predictors for lack of reperfusion after primary angioplasty in ST-elevation acute myocardial infarction
Cura, F.
Escudero, A. Garcia
Trivi, M.
Albertal, M.
Thierer, J.
Balino, P. Perez
Padilla, L.
Belardi, J.
CIRCULATION, 2008, 118 (12) : E462 - E463
[32] Anticoagulation Therapy in Non-ST-Segment Elevation Acute Coronary Syndrome
Curfman, Gregory
JAMA INTERNAL MEDICINE, 2019, 179 (02) : 195 - 195
[33] ST-elevation acute coronary syndrome in a patient after heart transplant
Browarek, Aldona
Debski, Artur
Tyczynski, Pawel
Piotrowska, Malgorzata
Zielinski, Tomasz
Sobieszczanska-Malek, Malgorzata
Karcz, Maciej
Witkowski, Adam
POSTEPY W KARDIOLOGII INTERWENCYJNEJ, 2014, 10 (01): : 60 - 62
[34] Cardioprotective strategy in ST-elevation acute myocardial infarction patients after reperfusion with percutaneous coronary intervention
Kozhukhov, S.
Parkhomenko, A.
Lutay, Y. A.
Yershova, Y.
EUROPEAN HEART JOURNAL, 2020, 41 : 1587 - 1587
[35] Acute coronary syndrome without ST-elevation (NSTE-ACS)
Rupprecht, H. J.
Geeren, Manfred
Geeren, Monika
Weilemann, S.
Schuster, H. P.
HERZ, 2019, 44 (01) : 10 - 15
[36] Reperfusion therapy in ST-elevation myocardial infarction: results from the Franche-Comte registry of acute coronary syndromes. Reasons for non-reperfusion therapy
Bassand, JP
EUROPEAN HEART JOURNAL, 2003, 24 : 200 - 200
[37] The correlation of plasma histamine and tryptase with ST-elevation acute myocardial infarction in acute coronary syndrome patients
Sukmana, M.
Putranto, J. N. E.
Soemantri, D.
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2016, 18 (0B) : B37 - B37
[38] EARLY PREDICTORS OF 30-DAY MORTALITY IN NON-ST-ELEVATION ACUTE CORONARY SYNDROME PATIENTS
Rozic, Suzana
Zupanic, Melanija
Sinkovic, Andreja
ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2008, 77 (09): : 553 - 560
[39] Predictors and etiologies of 30-day readmissions in patients with non-ST-elevation acute coronary syndrome
Lemor, Alejandro
Hernandez, Gabriel A.
Patel, Nish
Blumer, Vanessa
Sud, Karan
Cohen, Mauricio G.
De Marchena, Eduardo
Kini, Annapoorna S.
Sharma, Samin K.
Alfonso, Carlos E.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2019, 93 (03) : 373 - 379
[40] Reperfusion treatment of ST-elevation acute myocardial infarction
Ribichini, F
Ferrero, V
Wijns, W
PROGRESS IN CARDIOVASCULAR DISEASES, 2004, 47 (02) : 131 - 157

← 1 2 3 4 5 →